Supervisory agencies are investing in new surveillance technologies to better manage markets says Dan Barnes
"About eight years ago the price of MRI equipment and other
medical scanners became very cheap and firms began offering
low-cost, full-body scans to the public," recalls the head of
analytics at a US financial regulator. "The problem is that a
full scan of the average human body will find a huge number of
things that don’t fit in with the textbook. And so
people began having invasive procedures without any medical
problem. It quickly spiralled out of control."
Regulators are ramping up their investment in market
supervision systems to overcome data incompatibility and
outdated technology, but their new market microscopes must be
able to pick out real market problems, not hundreds of false
leads. Global regulators are swimming through a soup of
This article is available to subscribers and registered users
Please log in to continue reading.
Not yet registered? Take a free trial.
If you have already taken a free trial you
have ongoing access to the analysis section of FOW.com including this story.
Log in using your details below to read.
Already have an account? |